1004P Initial results from a phase I study of Nous-209, an off-the-shelf viral vectored immunotherapy encoding 209 shared frame shift peptide neoantigens, with pembrolizumab, for the treatment of tumors with a deficiency in mismatch repair/microsatellite instability
| Autor: | Overman, M.J., Leoni, G., D'Alise, A.M., Cotugno, G., Langone, F., Capone, S., Del Sorbo, M., Fakih, M., Le, D.T., Shields, A.F., Pedersen, K.S., Shah, M.A., Mukherjee, S., Delaite, P., Faivre, T., Scarselli, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S850-S850 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|